New hope for kids with leukemia in malawi: adapted treatment shows promise
NCT ID NCT06928909
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This study looks at whether a special treatment plan for children with acute myeloid leukemia (AML) can work well in Malawi, where resources are limited. About 30 children under 18 will receive a treatment guideline designed to balance curing the disease with manageable side effects. The goal is to see if most children can complete the treatment and achieve remission, while also tracking their quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKAEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kamuzu Central Hospital
RECRUITINGLilongwe, Lilongwe, Malawi
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new oral drug take on hard-to-treat leukaemia?
- Childhood leukaemia trial seeks best chemo cocktail
- New hope for AML patients: experimental drug IPN60340 enters key trial
- New hope for older blood cancer patients: smarter transplants aim to cut relapse
- New pill takes aim at genetic weakness in tough blood cancers
- Experimental immune cell therapy targets tough leukemia